Chemokine signaling in gliomas: prognostic factor, therapeutic target or both?
Krop
Ian E
IE
Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA. ikrop@partners.org
D001932:Brain Neoplasms / Q000378:metabolism*; D018925:Chemokines / Q000378:metabolism*; D005910:Glioma / Q000378:metabolism*; D006801:Humans; D019707:Receptors, Chemokine / Q000378:metabolism; D015398:Signal Transduction
D018925:Chemokines; D019707:Receptors, Chemokine